[23–27] Since it was initially demonstrated that genetic polymorphisms of mTOR were associated with human cancer risk as well as clinical outcomes, [14] several reports have explored the influence of genetic variants in the mTOR signaling pathway on carcinogenesis, disease progression, and disease prognosis. This evidence concerns the gene MTOR and cancer.